Nuvalent, Inc. (NUVL)
100.81
-1.27
(-1.24%)
USD |
NASDAQ |
Feb 11, 13:14
Nuvalent EPS Diluted (Quarterly) : -1.697 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -122.44M |
| Total Expenses (Quarterly) | 122.44M |
| Enterprise Value | 6.479B |
| Earnings Yield | -5.27% |
| Normalized Earnings Yield | -4.997 |